Stocks · Korea
049960
KOSDAQ
Cell Biotech CO
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER10.29x
PBR0.79x
EPS1,479 KRW
BPS19,234 KRW
ROE10.08%
Dividend yield3.94%
DPS600 KRW
Payout ratio40.57%
Returns and 52-week range
1W+1.06%
1M-3.91%
3M-0.13%
6M+5.69%
1Y+20.51%
YTD+16.81%
52W high18,500원
52W low11,350원
From 52W high-17.73%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 505억 | 61억 | 83억 | 12.0% |
| 2023 | 538억 | 22억 | 63억 | 4.1% |
| 2024 | 499억 | 68억 | 151억 | 13.6% |
| 2025 | 531억 | 79억 | 101억 | 14.9% |
| Quarterly | ||||
| 2024 4Q | 122억 | 11억 | 69억 | 9.3% |
| 2025 1Q | 112억 | 14억 | 21억 | 12.1% |
| 2025 2Q | 119억 | 13억 | 2억 | 10.8% |
| 2025 3Q | 154억 | 22억 | 34억 | 14.4% |
| 2025 4Q | 146억 | 31억 | 44억 | 20.9% |
| 2026 1Q | 146억 | 32억 | 54억 | 21.8% |
Company
Address: 경기 김포시 월곶면 개곡리 134
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.